IPCA Labs aims to make plants US FDA-compliant by December
IPCA Laboratories Ltd is aiming to make all of its plants facing import alerts from the United States compliant with U.S. Food and Drug Administration (FDA) rules by December, an executive said on Wednesday.
Mar 25, 2015, 13:51 PM IST
IPCA slumps as FDA bans imports from 2 more plants
Shares in generic drugmaker IPCA Laboratories slumped as much 12.7 percent, heading towards their biggest daily fall since July 2014, after the U.S. Food and Drug Administration (FDA) issued an import alert against two of its plants.
Mar 25, 2015, 13:18 PM IST
Actavis mulls job cuts, China expansion: Report
Generic drugmaker Actavis Plc is planning to cut employees and expand in China, a news report said citing an interview by Chief Executive Officer Brent Saunders on Bloomberg Television.
Nov 25, 2014, 08:33 AM IST
Ranbaxy to pay $40 million to settle Texas litigation
The payments will be made in tranches through August 2015.
Oct 16, 2014, 10:00 AM IST
Ranbaxy says US authorities seek information on pricing data
The company said it had received a civil investigative demand (CID) from the US Department of Justice (DOJ) and that it would fully cooperate with the investigation.
Sep 17, 2014, 18:23 PM IST
